Literature DB >> 2479692

Altered VH gene segment utilization in the response to phosphorylcholine by aged mice.

S C Riley1, B G Froscher, P J Linton, D Zharhary, K Marcu, N R Klinman.   

Abstract

Newly generated bone marrow B cell precursors of aged BALB/c mice, stimulated in splenic fragment cultures, display a markedly increased frequency of phosphorylcholine (PC)-responsive cells. This increased frequency is found for both precursors that utilize VHS107, a phenotype common to essentially all PC-specific B cells of young mice, and, surprisingly, for precursors that utilize VH genes other than VHS107. PC-specific hybridomas derived from bone marrow cells of aged mice utilize members of at least three VH gene segment families that have never been observed in PC responses of young mice. The ability of aged but not young mice to generate these unique PC-specific clonotypes may be evidence for constraints on V region utilization during repertoire development in young adults and has important implications for aging-associated changes in immune responsiveness.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2479692

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  17 in total

Review 1.  Impaired B lymphopoiesis in old age: a role for inflammatory B cells?

Authors:  Richard L Riley
Journal:  Immunol Res       Date:  2013-12       Impact factor: 2.829

Review 2.  Inflammatory immune cells may impair the preBCR checkpoint, reduce new B cell production, and alter the antibody repertoire in old age.

Authors:  Richard L Riley; Kelly Khomtchouk; Bonnie B Blomberg
Journal:  Exp Gerontol       Date:  2018-02-07       Impact factor: 4.032

3.  Relationship between naturally occurring human antibodies to casein and autologous antiidiotypic antibodies: implications for the network theory.

Authors:  C Cunningham-Rundles; Z K Feng; Z Zhou; K R Woods
Journal:  J Clin Immunol       Date:  1991-09       Impact factor: 8.317

Review 4.  Somatic diversification of antibody responses.

Authors:  B Zheng; G Kelsoe; S Han
Journal:  J Clin Immunol       Date:  1996-01       Impact factor: 8.317

5.  Age-Associated B Cells Express a Diverse Repertoire of VH and Vκ Genes with Somatic Hypermutation.

Authors:  Lisa M Russell Knode; Martin S Naradikian; Arpita Myles; Jean L Scholz; Yi Hao; Danya Liu; Mandy L Ford; John W Tobias; Michael P Cancro; Patricia J Gearhart
Journal:  J Immunol       Date:  2017-01-16       Impact factor: 5.422

6.  In old BALB/c mice, bone marrow pre-B cell and surrogate light chain reduction is associated with increased B cell reactivity to phosphorylcholine, but reduced T15 idiotype dominance.

Authors:  Kelly Khomtchouk; Sarah Alter; Michelle Ratliff; Bonnie B Blomberg; Richard L Riley
Journal:  Mech Ageing Dev       Date:  2016-11-19       Impact factor: 5.432

7.  Age-dependent appearance of non-major histocompatibility complex-restricted helper T cells.

Authors:  C Russo; E P Cherniack; A Wali; M E Weksler
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-15       Impact factor: 11.205

8.  Deviation of the B cell pathway in senescent mice is associated with reduced surrogate light chain expression and altered immature B cell generation, phenotype, and light chain expression.

Authors:  Sarah Alter-Wolf; Bonnie B Blomberg; Richard L Riley
Journal:  J Immunol       Date:  2009-01-01       Impact factor: 5.422

9.  Facultative role of germinal centers and T cells in the somatic diversification of IgVH genes.

Authors:  C Miller; J Stedra; G Kelsoe; J Cerny
Journal:  J Exp Med       Date:  1995-04-01       Impact factor: 14.307

10.  Defective B cell ontogeny and humoral immune response in mice prematurely expressing human complement receptor 2 (CR2, CD21) is similar to that seen in aging wild type mice.

Authors:  Jason P Twohig; Isabel Y Pappworth; Baalasubramanian Sivasankar; Liudmila Kulik; Melanie Bull; V Michael Holers; Eddie C Y Wang; Kevin J Marchbank
Journal:  Mol Immunol       Date:  2009-04-08       Impact factor: 4.407

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.